TABLE 2.
Afatinib | Crizotinib | Dabrafenib | Daporinad | Dasatinib | Erlotinib |
Gefitinib | Lapatinib | Leflunomide | Linsitinib | MK-1775 | Navitoclax |
Nilotinib | Osimertinib | Palbociclib | Ribociclib | Ruxolitinib | Sorafenib |
Staurosporine | Tamoxifen | Trametinib | Ulixertinib | Vinblastine | Vorinostat |